Cargando…

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study

AIMS: We aimed to assess and characterize sex differences in adverse drug reactions (ADRs) reported to the national pharmacovigilance centre in the Netherlands while considering differences in drug use. METHODS: ADRs spontaneously reported by healthcare professionals and patients to the Netherlands...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Sieta T., Denig, Petra, Ekhart, Corine, Burgers, Jako S., Kleefstra, Nanno, Mol, Peter G.M., van Puijenbroek, Eugène P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595313/ https://www.ncbi.nlm.nih.gov/pubmed/30941789 http://dx.doi.org/10.1111/bcp.13923

Ejemplares similares

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2020)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care
por: Denig, Petra, et al.
Publicado: (2019)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
por: Schreuder, Nanno, et al.
Publicado: (2020)

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
por: de Vries, Esther, et al.
Publicado: (2020)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
por: Ambrož, Martina, et al.
Publicado: (2022)

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study
por: de Vries, Sieta T, et al.
Publicado: (2014)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
por: Ambrož, Martina, et al.
Publicado: (2022)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
por: Dittrich, Anne T. M., et al.
Publicado: (2020)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients
por: Ambrož, Martina, et al.
Publicado: (2020)

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
por: Oosterhuis, Ingrid, et al.
Publicado: (2022)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
por: de Vries, Sieta T., et al.
Publicado: (2018)

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands
por: de Vries, Esther, et al.
Publicado: (2022)

Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty
por: Ambrož, Martina, et al.
Publicado: (2020)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre
por: Habarugira, Jean Marie Vianney, et al.
Publicado: (2021)

Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
por: Schreuder, Nanno, et al.
Publicado: (2020)

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
por: Dittrich, Anne T. M., et al.
Publicado: (2022)

Practising person-centred care. Selected abstracts from the virtual 26th WONCA Europe conference, 6–10 July 2021
por: Burgers, Jako S., et al.
Publicado: (2021)

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study
por: de Vries, Sieta T., et al.
Publicado: (2016)

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Anaphylactic Reaction to Tc-99m Macrosalb
por: Schreuder, Nanno, et al.
Publicado: (2019)

Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
por: Rulisa, Stephen, et al.
Publicado: (2012)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016
por: Oreagba, Ibrahim A., et al.
Publicado: (2017)

A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases
por: Brabete, Andreea C., et al.
Publicado: (2022)

Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2021)

Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
por: Bots, Sophie H., et al.
Publicado: (2022)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8oleara0pfrejqss4f1bojh9oo